FISH
With New Partnerships, Diaceutics Works to Standardize CDx Testing Globally
The deals with three quality assessment organizations will contribute to the firm's goal of connecting pharmaceutical companies, diagnostic firms, and laboratories.
Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer
The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis.
The company's approach involves using both fluorescence in situ hybridization and next-generation sequencing to provide clinicians with information.
The team will present the results to the US Food and Drug Administration as part of a 510(k) application in order to commercialize the technology with Biofluidica.
Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent
The company said that diagnostic testing volumes, product and royalty revenues, and clinical services revenues all fell year over year.